home / press / releases

Menu
  • Search all tables

releases: http://burgess.house.gov/blog/?postid=402994

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
http://burgess.house.gov/blog/?postid=402994 Burgess: Moderna vaccine adds dose of hope for the new year 2020-12-18 2020 2020-12 Republican Senate TX Michael Burgess B001248 burgess.house.gov     legacy Washington, D.C. Congressman Michael C. Burgess, M.D. (R-TX), a member of the House Rules Committee and Republican Leader of the House Energy and Commerce Subcommittee on Health,released the following statement after the Food and Drug Administration (FDA) approved an Emergency Use Authorization for Moderna's novel Coronavirus 2019 vaccine. There is something special about this time of year and having a second Coronavirus vaccine approved for emergency use adds to the joy of the season, said Burgess. In a span of one week, we have witnessed two vaccines receive Emergency Use Authorizations from the FDA. This is a shining example of American resourcefulness and the successful work done through Operation Warp Speed. I want to thank President Trump for putting American innovation first, our scientists and medical community, and the countless volunteers who have stepped up during this pandemic to serve on the front lines. This second vaccine is a signal that we are nearing the end of this pandemic, but we cannot stop taking the proper precautions especially now that cold and flu season is in full swing. Please continue to wash your hands thoroughly, wear a mask if you are unable to properly social distance, and stay home if you are sick. At the start of this pandemic, America declared that we are in this together and together we will reach the end. 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 0.715ms · Data license: MIT · Data source: dwillis/congress-press